rs201967064
Positions:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_001080463.2(DYNC2H1):c.6551A>T(p.Asp2184Val) variant causes a missense change. The variant allele was found at a frequency of 0.000149 in 1,611,332 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00093 ( 1 hom., cov: 32)
Exomes 𝑓: 0.000068 ( 0 hom. )
Consequence
DYNC2H1
NM_001080463.2 missense
NM_001080463.2 missense
Scores
1
1
17
Clinical Significance
Conservation
PhyloP100: 5.87
Genes affected
DYNC2H1 (HGNC:2962): (dynein cytoplasmic 2 heavy chain 1) This gene encodes a large cytoplasmic dynein protein that is involved in retrograde transport in the cilium and has a role in intraflagellar transport, a process required for ciliary/flagellar assembly. Mutations in this gene cause a heterogeneous spectrum of conditions related to altered primary cilium function and often involve polydactyly, abnormal skeletogenesis, and polycystic kidneys. Alternative splicing results in multiple transcript variants encoding distinct proteins. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0069859624).
BP6
Variant 11-103184969-A-T is Benign according to our data. Variant chr11-103184969-A-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 281769.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=3, Uncertain_significance=3}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DYNC2H1 | NM_001080463.2 | c.6551A>T | p.Asp2184Val | missense_variant | 41/90 | ENST00000650373.2 | NP_001073932.1 | |
DYNC2H1 | NM_001377.3 | c.6551A>T | p.Asp2184Val | missense_variant | 41/89 | ENST00000375735.7 | NP_001368.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DYNC2H1 | ENST00000650373.2 | c.6551A>T | p.Asp2184Val | missense_variant | 41/90 | NM_001080463.2 | ENSP00000497174 | A1 | ||
DYNC2H1 | ENST00000375735.7 | c.6551A>T | p.Asp2184Val | missense_variant | 41/89 | 1 | NM_001377.3 | ENSP00000364887 | P3 | |
DYNC2H1 | ENST00000334267.11 | c.2205+50550A>T | intron_variant | 1 | ENSP00000334021 | |||||
DYNC2H1 | ENST00000649323.1 | c.*4096A>T | 3_prime_UTR_variant, NMD_transcript_variant | 39/51 | ENSP00000497581 |
Frequencies
GnomAD3 genomes AF: 0.000915 AC: 139AN: 151916Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
139
AN:
151916
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000189 AC: 47AN: 248402Hom.: 0 AF XY: 0.000119 AC XY: 16AN XY: 134764
GnomAD3 exomes
AF:
AC:
47
AN:
248402
Hom.:
AF XY:
AC XY:
16
AN XY:
134764
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000678 AC: 99AN: 1459298Hom.: 0 Cov.: 30 AF XY: 0.0000537 AC XY: 39AN XY: 725916
GnomAD4 exome
AF:
AC:
99
AN:
1459298
Hom.:
Cov.:
30
AF XY:
AC XY:
39
AN XY:
725916
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000927 AC: 141AN: 152034Hom.: 1 Cov.: 32 AF XY: 0.000915 AC XY: 68AN XY: 74312
GnomAD4 genome
AF:
AC:
141
AN:
152034
Hom.:
Cov.:
32
AF XY:
AC XY:
68
AN XY:
74312
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
15
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
32
Asia WGS
AF:
AC:
2
AN:
3476
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:4
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jul 28, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Mar 17, 2020 | The sequence change, c.6551A>T, in exon 41 that results in an amino acid change, p.Asp2184Val. This sequence change has been previously reported in product of conception samples of a couple with recurrent miscarriages in the compound heterozygous state along with other missense change, p.Tyr2016Cys, in the same gene (PMID: 26826164). No functional studies were performed. This sequence change has been described in the gnomAD database with a low population frequency of 0.32% in the African subpopulation (dbSNP rs201967064). The p.Asp2184Val change affects a moderately conserved amino acid residue located in a domain of the DYNC2H1 protein that is known to be functional. The p.Asp2184Val substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to these contrasting evidences and the lack of functional studies, the clinical significance of the p.Asp2184Val change remains unknown at this time. - |
Likely benign, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 20, 2024 | Variant summary: DYNC2H1 c.6551A>T (p.Asp2184Val) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a neutral effect of the variant on protein function. The variant allele was found at a frequency of 0.00019 in 248402 control chromosomes, predominantly at a frequency of 0.0028 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is slightly higher than the estimated maximal expected allele frequency for a pathogenic variant in DYNC2H1 causing Short-rib thoracic dysplasia phenotype (0.0025), suggesting that the variant is a benign polymorphism found primarily in populations of African or African-American origin. c.6551A>T has been reported in the literature in one individual affected with recurrent early pregnancy loss. These report(s) do not provide unequivocal conclusions about association of the variant with Short-rib thoracic dysplasia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26826164). ClinVar contains an entry for this variant (Variation ID: 281769). Based on the evidence outlined above, the variant was classified as likely benign. - |
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Mar 25, 2018 | The DYNC2H1 c.6551A>T; p.Asp2184Val variant (rs201967064, ClinVar variant ID 281769) was found in the compound heterozygous state along with another DYNC2H1 variant (p.Tyr2016Cys) in two miscarriages from a family with recurrant pregnancy loss (Qiao 2106). This variant is listed in the genome Aggregation Database (gnomAD) with an African population frequency of 0.3% (identified on 75 out of 23,960 chromosomes). The aspartic acid at position 2184 is moderately conserved, considering 28 species, and computational analyses of the effects of the p.Asp2184Val variant on protein structure and function do not predict a deleterious effect (SIFT: tolerated, PolyPhen-2: benign). Based on the available information, the clinical significance of the p.Asp2184Val variant cannot be determined with certainty. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Apr 26, 2022 | Identified in the the heterozygous state in an indvidual whose partner had recurrent miscarriage and was heterozygous for another variant in the DYNC2H1 gene (Qiao et al., 2016); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 26826164) - |
Jeune thoracic dystrophy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | - - |
DYNC2H1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 12, 2023 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Pathogenic
D
LIST_S2
Benign
.;T;.;T
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L;L;L
MutationTaster
Benign
D;D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;.;.;D
REVEL
Benign
Sift
Benign
T;.;.;T
Sift4G
Benign
T;.;.;T
Polyphen
B;B;B;B
Vest4
MVP
MPC
0.098
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at